Search - tctmd.com

Displaying 21 - 40 of 43

Sort: Relevancy | Date

News Industry News

Significant Patient Benefits With Edwards SAPIEN Valve Demonstrated In 5-Year PARTNER Trial Data

September 13, 2014

News Industry News

Clinical Trial Examines the Long Term Outcomes of a Self-Expanding Transcatheter Aortic Valve in Inoperable Patients with Aortic Stenosis

September 13, 2014

News Industry News

5 Year Data from Clinical Trial Studying TAVR in Patients with Severe Aortic Stenosis Demonstrates Persistent Mortality Benefit and Lower Rate of Repeat Hospitalizations Compared to Standard Therapy

September 13, 2014

News Industry News

Minneapolis Heart Institute Foundation Announces Its First Implant of Portico Aortic Heart Valve System

August 18, 2014

News Industry News

Edwards Lifesciences Launching SAPIEN XT Valve in the U.S.

June 16, 2014

News Industry News

St. Jude Medical Announces First Implants in US Study of the Portico Transcatheter Aortic Heart Valve System

May 13, 2014

News Industry News

Medtronic Reveals Positive Outcomes for CoreValve® Patients Treated via Alternative Access Routes

April 29, 2014

News Industry News

St. Jude Medical Reports Positive Clinical Outcomes from Portico Heart Valve Study

October 29, 2013

News Industry News

Boston Scientific Receives CE Mark For Lotus™ Valve System

October 28, 2013

News Industry News

Positive Patient Outcomes at One Year With Edwards Sapien XT Transcatheter Valve

May 21, 2013

News Industry News

Direct Flow Medical® Receives IDE Approval for U.S. Salus Trial of Transcatheter Aortic Heart Valve System

May 16, 2013

News Industry News

Survival of SAPIEN High-Risk Patients Equivalent to Surgery at Three Years

March 11, 2013

News Industry News

Study Confirms Benefits of Transcatheter Aortic Valve Replacement Over Three Years

October 24, 2012

News Industry News

FDA Approves Expanded Indication for Edwards Lifesciences' Transcatheter Valve

October 19, 2012

News Industry News

Edwards SAPIEN XT Transcatheter Valve Continues to Achieve Positive Patient Outcomes in 94 Center Post-Approval Study

May 17, 2012

News Industry News

Two-year study of transcatheter aortic valve replacement demonstrates continued superiority over standard therapy

November 09, 2011

News Industry News

TAVI at TCT: Enthusiasm Tempered by Poor Transapical Outcomes

November 09, 2011

News Industry News

Quality of life benefits of transcatheter aortic valve replacement differ by access site

November 09, 2011

News Industry News

Quality of Life and Economic Analyses of Edwards SAPIEN Valve in High-Risk Patients Featured at TCT

November 09, 2011

News Industry News

New analysis measures cost effectiveness of transcatheter aortic valve replacement compared to surgical valve replacement

November 09, 2011

Advertisement

Significant Patient Benefits With Edwards SAPIEN Valve Demonstrated In 5-Year PARTNER Trial Data

Clinical Trial Examines the Long Term Outcomes of a Self-Expanding Transcatheter Aortic Valve in Inoperable Patients with Aortic Stenosis

5 Year Data from Clinical Trial Studying TAVR in Patients with Severe Aortic Stenosis Demonstrates Persistent Mortality Benefit and Lower Rate of Repeat Hospitalizations Compared to Standard Therapy

Minneapolis Heart Institute Foundation Announces Its First Implant of Portico Aortic Heart Valve System

Edwards Lifesciences Launching SAPIEN XT Valve in the U.S.

St. Jude Medical Announces First Implants in US Study of the Portico Transcatheter Aortic Heart Valve System

Medtronic Reveals Positive Outcomes for CoreValve® Patients Treated via Alternative Access Routes

St. Jude Medical Reports Positive Clinical Outcomes from Portico Heart Valve Study

Boston Scientific Receives CE Mark For Lotus™ Valve System

Positive Patient Outcomes at One Year With Edwards Sapien XT Transcatheter Valve

Direct Flow Medical® Receives IDE Approval for U.S. Salus Trial of Transcatheter Aortic Heart Valve System

Survival of SAPIEN High-Risk Patients Equivalent to Surgery at Three Years

Study Confirms Benefits of Transcatheter Aortic Valve Replacement Over Three Years

FDA Approves Expanded Indication for Edwards Lifesciences' Transcatheter Valve

Edwards SAPIEN XT Transcatheter Valve Continues to Achieve Positive Patient Outcomes in 94 Center Post-Approval Study

Two-year study of transcatheter aortic valve replacement demonstrates continued superiority over standard therapy

TAVI at TCT: Enthusiasm Tempered by Poor Transapical Outcomes

Quality of life benefits of transcatheter aortic valve replacement differ by access site

Quality of Life and Economic Analyses of Edwards SAPIEN Valve in High-Risk Patients Featured at TCT

New analysis measures cost effectiveness of transcatheter aortic valve replacement compared to surgical valve replacement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content